162 related articles for article (PubMed ID: 3581069)
1. Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs.
Wollner IS; Knutsen CA; Ullrich KA; Chrisp CE; Juni JE; Andrews JC; Tuscan MJ; Stetson PL; Ensminger WD
Cancer Res; 1987 Jun; 47(12):3285-90. PubMed ID: 3581069
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.
Ensminger WD; Walker SC; Stetson PL; Wagner JG; Knol JA; Lawrence TS; Andrews JC
Cancer Res; 1994 Apr; 54(8):2121-4. PubMed ID: 8174116
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatic arterial yttrium 90 glass microspheres in dogs.
Wollner I; Knutsen C; Smith P; Prieskorn D; Chrisp C; Andrews J; Juni J; Warber S; Klevering J; Crudup J
Cancer; 1988 Apr; 61(7):1336-44. PubMed ID: 3345490
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
6. Computer modeling of yttrium-90-microsphere transport in the hepatic arterial tree to improve clinical outcomes.
Kennedy AS; Kleinstreuer C; Basciano CA; Dezarn WA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):631-7. PubMed ID: 19910131
[TBL] [Abstract][Full Text] [Related]
7. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.
Knol JA; Walker SC; Robertson JM; Yang Z; DeRemer S; Stetson PL; Ensminger WD; Lawrence TS
Cancer Res; 1995 Sep; 55(17):3687-91. PubMed ID: 7641176
[TBL] [Abstract][Full Text] [Related]
14. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
[TBL] [Abstract][Full Text] [Related]
15. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
Konda A; Savin MA; Cappell MS; Duffy MC
Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy.
Roberson PL; Ten Haken RK; McShan DL; McKeever PE; Ensminger WD
J Nucl Med; 1992 May; 33(5):735-8. PubMed ID: 1569483
[TBL] [Abstract][Full Text] [Related]
17. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
19. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer.
Yan ZP; Lin G; Zhao HY; Dong YH
Cancer; 1993 Dec; 72(11):3210-5. PubMed ID: 8242543
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]